Lupin Ltd

  • BSE Code : 500257
  • NSE Symbol : LUPIN
  • ISIN : INE326A01037
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 1,969.50 -39.10(-1.95%)

Open Price (₹)

1,990.00

Prev. Close (₹)

2,008.60

Volume (No’s)

540,357

Market Cap (₹)

91,851.87

Low Price (₹)

1,944.10

High Price (₹)

1,994.70

 

Corporate Announcement

04-Nov-2026 Lupin Limited - Investor Presentation
23-Oct-2026 Lupin Limited - ESOP/ESOS/ESPS
19-Oct-2026 Lupin Limited - Analysts/Institutional Investor Meet/Con. Call Updates
06-Oct-2026 Lupin Limited - Press Release
28-Sep-2026 Lupin Limited - Trading Window

Stock Summary

Market Cap(₹Cr.)

92,144.54

P/E (TTM)

13.92

Book value (₹)

658.96

Div Yield (%)

0.89

EPS (TTM)

144.8

Face Value (₹)

2.00

Technical Analysis

Key Level

Resistance 1

₹2,045.63

Resistance 2

₹2,082.67

Support 1

₹1,988.03

Support 2

₹1,967.47

Moving Average

30 Days

₹1,999.92

50 Days

₹2,050.21

100 Days

₹2,213.15

200 Days

₹2,240.51

Peers Group

Company Market Cap (₹in Cr.) P/E (x) P/B(x) EV / EBITDA(x) Dividend Yield(%) EPS
Lupin Ltd 92,144.54 13.92 3.51 8522.9 0.89 144.8
Sun Pharmaceutical Indust.. 426,121.89 122.06 18.85 6053.68 0.9 14.55
Divis Laboratories Ltd 266,424.27 88.93 9.43 3921 0.3 112.85
Torrent Pharmaceuticals L.. 179,914.00 92.33 16.9 4001.11 0.71 51.23
Laurus Labs Ltd 124,601.40 119.24 10.19 1515.69 0.09 19.34

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made investment of ₹ Returns(%)

in Months Ago

My investment would be worth₹ with a Loss of

Share Holding

CATEGORY NO. OF SHARES PERCENTAGE (%)
Total Foreign 107951035 23.61
Total Institutions 108760091 23.78
Total Govt Holding 9711 0.00
Total Non Promoter Corporate Holding 1338121 0.29
Total Promoters 214217374 46.85
Total Public & others 25013640 5.47
Total 457289972 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

Corporate Actions

About Company

Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments.

Lupin Limited was incorporated in 1983 as 'Lupin Chemicals Limited'. In March 2001, Lupin Laboratories Limited was amalgamated with the company and the name was changed to 'Lupin Limited'. In 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar. In 1989, the company established a joint venture in Thailand, namely Lupin Chemicals (Thailand) Ltd. In the year 1991, they initiated production of Injectable cephalosporin (bulk and dosages) at Mandideep. In 1992, the company set up Fermentation Plant at Tarapur, Maharashtra. Also, Sterile Plant for injectable Cephalosporins (bulk) was commissioned at Mandideep.

They commenced supply of Cephalosporin bulk actives to their alliance partners in the US. Also, they commissioned a...

BSE Delayed data sourced at 5 mins : www.bseindia.com | NSE Delayed data sourced at 15 mins : www.nseindia.com

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew